The impact of telemonitoring on correct drug use, complications and quality of life among patients with multiple myeloma (ITUMM): A study protocol for an open-label, parallel-group, randomized controlled trial
Authors
Paul A. F. Geerts (ORCID: https://orcid.org/0000-0002-1737-7133)
Job F. H. Eijsink (ORCID: https://orcid.org/0000-0001-5442-0789)
Jan Gerard Maring (ORCID: https://orcid.org/0009-0009-8533-9233)
The impact of telemonitoring on correct drug use, complications and quality of life among patients with multiple myeloma (ITUMM): A study protocol for an open-label, parallel-group, randomized controlled trial
Paul A. F. Geerts, Job F. H. Eijsink, Jan Gerard Maring, Cornelis Boersma et al.
Citations
1 citations
Journal
PLoS ONE
Topics
Multiple Myeloma Research and Treatments
Field-Weighted Citation Impact (FWCI)
0.45
article
The impact of telemonitoring on correct drug use, complications and quality of life among patients with multiple myeloma (ITUMM): A study protocol for an open-label, parallel-group, randomized controlled trial
Paul A. F. Geerts, Job F. H. Eijsink, Jan Gerard Maring, Cornelis Boersma, Maarten Jacobus Postma, Mireille A. Edens, Peter G. J. ter Horst, K. L. Kamminga
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
PLoS ONEVol. 19(8)
Institutions
University Medical Center Groningen (NL), University of Groningen (NL), Isala (NL), Open University of the Netherlands (NL)